Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-02-10 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Parties | MSD INTERNATIONAL BUSINESS GMBH | ||
Patents | 7,449,464; 8,475,842; 8,859,562 | ||
Attorneys | CHARLES H. CHEVALIER | ||
Firms | Midlige Richter LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED
Details for ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-02-10 | 1 | Complaint | expiration of U.S. Patent No. 7,449,464 (“the ’464”); U.S. Patent No. 8,475,842 (“the ’842 patent”); and U.S.…U.S. Patent No. 8,859,562 (“the ’562 patent”). These patents are referred to collectively herein as the… the ’842 patent, including at least claims 1 and 7 of the ’842 patent, and the ’842 patent has been … 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…United States Patent and Trademark Office (the “USPTO”) duly and lawfully issued the ’464 patent, entitled | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |